|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0007131,
umls-concept:C0017262,
umls-concept:C0030705,
umls-concept:C0040085,
umls-concept:C0058126,
umls-concept:C0185117,
umls-concept:C0475358,
umls-concept:C1446539,
umls-concept:C1514307,
umls-concept:C1521801,
umls-concept:C2911684
|
|
pubmed:issue |
4C
|
|
pubmed:dateCreated |
2007-8-15
|
|
pubmed:abstractText |
UFT (tegafur + uracil) has been reported to be effective as an adjuvant in postoperative chemotherapy for non-small cell lung cancer (NSCLC) in a randomized prospective study. Thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) expression were investigated in resected tumors and the relationship between their expression and clinical factors in NSCLC patients was examined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0250-7005
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2641-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:17695427-Adult,
pubmed-meshheading:17695427-Aged,
pubmed-meshheading:17695427-Aged, 80 and over,
pubmed-meshheading:17695427-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:17695427-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:17695427-Dihydrouracil Dehydrogenase (NADP),
pubmed-meshheading:17695427-Female,
pubmed-meshheading:17695427-Humans,
pubmed-meshheading:17695427-Immunohistochemistry,
pubmed-meshheading:17695427-Lung Neoplasms,
pubmed-meshheading:17695427-Lymph Node Excision,
pubmed-meshheading:17695427-Male,
pubmed-meshheading:17695427-Middle Aged,
pubmed-meshheading:17695427-Neoplasm Staging,
pubmed-meshheading:17695427-Tegafur,
pubmed-meshheading:17695427-Thymidylate Synthase,
pubmed-meshheading:17695427-Uracil
|
|
pubmed:articleTitle |
Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer.
|
|
pubmed:affiliation |
Department of Oncological and Regenerative Surgery, Institute of Health Bioscience, University of Tokushima Graduate School, Kuramoto-cho, Tokushima, Japan.
|
|
pubmed:publicationType |
Journal Article
|
